|
1
|
Karpik M and Reszec J: Low grade
chondrosarcoma-epidemiology, diagnosis, treatment. Ortop Traumatol
Rehabil. 20:65–70. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Boehme KA, Schleicher SB, Traub F and
Rolauffs B: Chondrosarcoma: A rare misfortune in aging human
cartilage? The role of stem and progenitor cells in proliferation,
malignant degeneration and therapeutic resistance. Int J Mol Sci.
19:3112018. View Article : Google Scholar
|
|
3
|
Chow WA: Chondrosarcoma: Biology,
genetics, and epigenetics. F1000Res. 7:F1000 Faculty Rev-1826.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Leddy LR and Holmes RE: Chondrosarcoma of
bone. Cancer Treat Res. 162:117–130. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Mery B, Espenel S, Guy JB, Rancoule C,
Vallard A, Aloy MT, Rodriguez-Lafrasse C and Magné N: Biological
aspects of chondrosarcoma: Leaps and hurdles. Crit Rev Oncol
Hematol. 126:32–36. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Andreou D, Ruppin S, Fehlberg S, Pink D,
Werner M and Tunn PU: Survival and prognostic factors in
chondrosarcoma: Results in 115 patients with long-term follow-up.
Acta Orthop. 82:749–755. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wan L, Tu C, Li S and Li Z: Regional lymph
node involvement is associated with poorer survivorship in patients
with chondrosarcoma: A SEER analysis. Clin Orthop Relat Res.
477:2508–2518. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nie Z, Lu Q and Peng H: Prognostic factors
for patients with chondrosarcoma: A survival analysis based on the
Surveillance, Epidemiology, and End Results (SEER) database
(1973–2012). J Bone Oncol. 13:55–61. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Song K, Song J, Chen F, Lin K, Ma X and
Jiang J: Does resection of the primary tumor improve survival in
patients with metastatic chondrosarcoma? Clin Orthop Relat Res.
477:573–583. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Colella G, Fazioli F, Gallo M, De Chiara
A, Apice G, Ruosi C, Cimmino A and de Nigris F: Sarcoma spheroids
and organoids-promising tools in the Era of personalized medicine.
Int J Mol Sci. 19:6152018. View Article : Google Scholar
|
|
11
|
Brown HK, Tellez-Gabriel M and Heymann D:
Cancer stem cells in osteosarcoma. Cancer Lett. 386:189–195. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Rodriguez R, Rubio R and Menendez P:
Modeling sarcomagenesis using multipotent mesenchymal stem cells.
Cell Res. 22:62–77. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Hanahan D and Weinberg RA: The hallmarks
of cancer. Cell. 100:57–70. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Fouad YA and Aanei C: Revisiting the
hallmarks of cancer. Am J Cancer Res. 7:1016–1036. 2017.PubMed/NCBI
|
|
15
|
Ishiguro T, Ohata H, Sato A, Yamawaki K,
Enomoto T and Okamoto K: Tumor-derived spheroids: Relevance to
cancer stem cells and clinical applications. Cancer Sci.
108:283–289. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo X, Chen Y, Ji W, Chen X, Li C and Ge
R: Enrichment of cancer stem cells by agarose multi-well dishes and
3D spheroid culture. Cell Tissue Res. 375:397–408. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mehta P, Novak C, Raghavan S, Ward M and
Mehta G: Self-renewal and CSCs in vitro enrichment: Growth as
floating spheres. Methods Mol Biol. 1692:61–75. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ma R, Mandell J, Lu F, Heim T, Schoedel K,
Duensing A, Watters RJ and Weiss KR: Do patient-derived spheroid
culture models have relevance in chondrosarcoma research? Clin
Orthop Relat Res. May 19–2020.doi: 10.1097/CORR.0000000000001317.
(Epub ahead of print). View Article : Google Scholar
|
|
19
|
Fujii H, Honoki K, Tsujiuchi T, Kido A,
Yoshitani K and Takakura Y: Sphere-forming stem-like cell
populations with drug resistance in human sarcoma cell lines. Int J
Oncol. 34:1381–1386. 2009.PubMed/NCBI
|
|
20
|
Gao S, Shen J, Hornicek F and Duan Z:
Three-dimensional (3D) culture in sarcoma research and the clinical
significance. Biofabrication. 9:0320032017. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Gibbs CP, Kukekov VG, Reith JD,
Tchigrinova O, Suslov ON, Scott EW, Ghivizzani SC, Ignatova TN and
Steindler DA: Stem-like cells in bone sarcomas: Implications for
tumorigenesis. Neoplasia. 7:967–976. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Tang QL, Zhao ZQ, Li JC, Liang Y, Yin JQ,
Zou CY, Xie XB, Zeng YX, Shen JN, Kang T and Wang J: Salinomycin
inhibits osteosarcoma by targeting its tumor stem cells. Cancer
Lett. 311:113–121. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Galoyan AA, Shakhlamov VA, Aghajanov MI
and Vahradyan HG: Hypothalamic proline-rich polypeptide protects
brain neurons in aluminum neurotoxicosis. Neurochem Res.
29:1349–1357. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Galoian K, Abrahamyan S, Chailyan G,
Qureshi A, Patel P, Metser G, Moran A, Sahakyan I, Tumasyan N, Lee
A, et al: Toll like receptors TLR1/2, TLR6 and MUC5B as binding
interaction partners with cytostatic proline rich polypeptide 1 in
human chondrosarcoma. Int J Oncol. 52:139–154. 2018.PubMed/NCBI
|
|
25
|
Galoian K, Luo S, Qureshi A, Patel P,
Price R, Morse AS, Chailyan G, Abrahamyan S and Temple HT: Effect
of cytostatic proline rich polypeptide-1 on tumor suppressors of
inflammation pathway signaling in chondrosarcoma. Mol Clin Oncol.
5:618–624. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Galoian KA, Temple TH and Galoyan A:
Cytostatic effect of novel mTOR inhibitor, PRP-1 (galarmin) in MDA
231 (ER-) breast carcinoma cell line. PRP-1 inhibits mesenchymal
tumors. Tumour Biol. 32:745–751. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Galoian K, Scully S and Galoyan A:
Myc-oncogene inactivating effect by proline rich polypeptide
(PRP-1) in chondrosarcoma JJ012 cells. Neurochem Res. 34:379–385.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Galoian K, Scully S, McNamara G, Flynn P
and Galoyan A: Antitumorigenic effect of brain proline rich
polypeptide-1 in human chondrosarcoma. Neurochem Res. 34:2117–2121.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Galoian K, Qureshi A, Wideroff G and
Temple HT: Restoration of desmosomal junction protein expression
and inhibition of H3K9-specific histone demethylase activity by
cytostatic proline-rich polypeptide-1 leads to suppression of
tumorigenic potential in human chondrosarcoma cells. Mol Clin
Oncol. 3:171–178. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Hoyt AK, Moran A, Granger C, Sedani A,
Saigh S, Brown J and Galoian KA: PRP1 significantly decreases the
ALDHhigh cancer stem cell population and regulates the aberrant
Wnt/β-catenin pathway in human chondrosarcoma JJ012 cells. Oncol
Rep. 42:103–114. 2019.PubMed/NCBI
|
|
31
|
Horibata S, Vo TV, Subramanian V, Thompson
PR and Coonrod SA: Utilization of the soft agar colony formation
assay to identify inhibitors of tumorigenicity in breast cancer
cells. J Vis Exp. e527272015.PubMed/NCBI
|
|
32
|
Cesarz Z and Tamama K: Spheroid culture of
mesenchymal stem cells. Stem Cells Int. 2016:91763572016.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Dong G, Wang S, Ge Y, Deng Q, Cao Q, Wang
Q, Shang Z, OuYang W, Li J, Liu C, et al: Serum-free culture system
for spontaneous human mesenchymal stem cell spheroid formation.
Stem Cells Int. 2019:60418162019. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Rieger AM, Nelson KL, Konowalchuk JD and
Barreda DR: Modified annexin V/propidium iodide apoptosis assay for
accurate assessment of cell death. J Vis Exp. 25972011.PubMed/NCBI
|
|
35
|
Whelan JS and Davis LE: Osteosarcoma,
chondrosarcoma, and chordoma. J Clin Oncol. 36:188–193. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Mas A, Prusinski L, Yang Q, Diaz-Gimeno P,
Stone L, Diamond MP, Simón C and Al-Hendy A: Role of
Stro1+/CD44+ stem cells in myometrial
physiology and uterine remodeling during pregnancy. Biol Reprod.
96:70–80. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Galoczova M, Coates P and Vojtesek B:
STAT3, stem cells, cancer stem cells and p63. Cell Mol Biol Lett.
23:122018. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Fang Y and Eglen RM: Three-dimensional
cell cultures in drug discovery and development. SLAS Discov.
22:456–472. 2017.PubMed/NCBI
|
|
39
|
Song L, Yuan X, Jones Z, Zhou Y, Ma T and
Li Y: Assembly of human stem cell-derived cortical spheroids and
vascular spheroids to model 3-D brain-like tissues. Sci Rep.
9:59772019. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Leek R, Grimes DR, Harris AL and McIntyre
A: Methods: Using three-dimensional culture (Spheroids) as an in
vitro model of tumour hypoxia. Adv Exp Med Biol. 899:167–196. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Huang G, Ye S, Zhou X, Liu D and Ying QL:
Molecular basis of embryonic stem cell self-renewal: From signaling
pathways to pluripotency network. Cell Mol Life Sci. 72:1741–1757.
2015. View Article : Google Scholar : PubMed/NCBI
|
